tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Johnson & Johnson announces new long-term data from Quasar LTE study
PremiumThe FlyJohnson & Johnson announces new long-term data from Quasar LTE study
4d ago
Johnson & Johnson says Rybrevant Faspro shows strong clinical benefit
Premium
The Fly
Johnson & Johnson says Rybrevant Faspro shows strong clinical benefit
6d ago
J&J weighs sale of DePuy amid private equity interest, Bloomberg says
Premium
The Fly
J&J weighs sale of DePuy amid private equity interest, Bloomberg says
7d ago
Johnson & Johnson granted BTD for RYBREVANT FASPRO from FDA
PremiumThe FlyJohnson & Johnson granted BTD for RYBREVANT FASPRO from FDA
8d ago
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
Premium
The Fly
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
9d ago
Johnson & Johnson’s Rybrevant Faspro regimen approved by FDA for NSCLC
Premium
The Fly
Johnson & Johnson’s Rybrevant Faspro regimen approved by FDA for NSCLC
9d ago
Johnson & Johnson price target raised to $227 from $221 at BofA
PremiumThe FlyJohnson & Johnson price target raised to $227 from $221 at BofA
27d ago
PayPal downgraded, UPS upgraded: Wall Street’s top analyst calls
Premium
The Fly
PayPal downgraded, UPS upgraded: Wall Street’s top analyst calls
29d ago
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley
29d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100